Company Overview
Snapshot
Founded in June 2018 by Shachar Paz, Michal Marks, and Assaf Deutsch, NeuroTrigger operates with 1–10 employees. The company has secured $4.12 million across five funding rounds. A significant milestone was achieved in October 2023 when NeuroTrigger received FDA 510(k) clearance for its non-invasive muscle stimulation system (NTB).
Business overview
NeuroTrigger is a Health Tech & Life Sciences company focused on developing advanced muscle re-education systems. Its core product is a wearable, lightweight system comprising a rechargeable stimulator and a pre-gelled Y-shaped electrode, designed to deliver electrical pulses for muscle contraction. This technology aims to improve muscle performance, increase range of motion, and prevent disuse atrophy across various body parts, including facial musculature. The system integrates with a mobile application via Bluetooth, allowing users, caregivers, or technicians to monitor and adjust parameters. NeuroTrigger serves the medical devices market, targeting patients and healthcare providers with its non-invasive neuro-stimulation solutions.
Strategic signal
In October 2023, NeuroTrigger received FDA 510(k) clearance for its non-invasive muscle stimulation system (NTB). This regulatory approval is a critical validation of the company's technology and significantly de-risks its market entry and commercialization efforts within the medical device sector. For investors, this signals a clear path to broader market adoption and revenue generation, positioning NeuroTrigger for accelerated growth in the health tech space.
Log in to access full profile ›Company Intelligence Q&A
- What is NeuroTrigger's primary product?
- NeuroTrigger develops a wearable muscle re-education system that uses a rechargeable stimulator and pre-gelled electrodes to deliver electrical pulses for muscle contraction, aiming to improve performance and prevent atrophy.
- When was NeuroTrigger founded?
- NeuroTrigger was founded in June 2018.
- What significant regulatory milestone did NeuroTrigger achieve?
- In October 2023, NeuroTrigger received FDA 510(k) clearance for its non-invasive muscle stimulation system (NTB).
- Has NeuroTrigger received any grants?
- In July 2023, NeuroTrigger received a grant from the BIRD Foundation. Previously, in September 2019, the company secured a grant from the Israel Innovation Authority.
- How does NeuroTrigger's system integrate with mobile technology?
- NeuroTrigger's wearable stimulator communicates with a unique mobile phone application via Bluetooth, enabling users, caregivers, or technicians to monitor the stimulator's status and adjust various parameters.